Biofrontera AG
B8FK
Equity
ISIN DE000A4BGGM7 / Valor 135165522
Xetra (2026-02-20)
EUR 2.69%
Biofrontera AG
UMushroom community rating:
About company
Biofrontera AG is a biopharmaceutical company specializing in the development and commercialization of dermatological products for the treatment of skin diseases.
Summarized from source with an LLMView SourceSector: IndustrialsKey figures
8.25%1Y
-90.2%3Y
-95.6%5Y
Performance
42.1%1Y
80.8%3Y
70.7%5Y
Volatility
19 M
Market cap (USD)
Daily traded volume (Shares)
2.225 / 2.085
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
